These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 24692520

  • 1. Plasma fibrinogen along with patient-reported outcome measures enhances management of polymyalgia rheumatica: a prospective study.
    McCarthy EM, MacMullan PA, Al-Mudhaffer S, Madigan A, Donnelly S, McCarthy CJ, Molloy ES, Kenny D, McCarthy GM.
    J Rheumatol; 2014 May; 41(5):931-7. PubMed ID: 24692520
    [Abstract] [Full Text] [Related]

  • 2. Plasma fibrinogen is an accurate marker of disease activity in patients with polymyalgia rheumatica.
    McCarthy EM, MacMullan PA, Al-Mudhaffer S, Madigan A, Donnelly S, McCarthy CJ, Molloy ES, Kenny D, McCarthy GM.
    Rheumatology (Oxford); 2013 Mar; 52(3):465-71. PubMed ID: 23125391
    [Abstract] [Full Text] [Related]

  • 3. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study.
    Cantini F, Salvarani C, Olivieri I, Macchioni L, Ranzi A, Niccoli L, Padula A, Boiardi L.
    Semin Arthritis Rheum; 2000 Aug; 30(1):17-24. PubMed ID: 10966209
    [Abstract] [Full Text] [Related]

  • 4. Patient-reported outcomes in polymyalgia rheumatica.
    Matteson EL, Maradit-Kremers H, Cimmino MA, Schmidt WA, Schirmer M, Salvarani C, Bachta A, Dejaco C, Duftner C, Slott Jensen H, Poór G, Kaposi NP, Mandl P, Balint PV, Schmidt Z, Iagnocco A, Cantini F, Nannini C, Macchioni P, Pipitone N, Del Amo M, Espígol-Frigolé G, Cid MC, Martínez-Taboada VM, Nordborg E, Direskeneli H, Aydin SZ, Ahmed K, Hazelman B, Pease C, Wakefield RJ, Luqmani R, Abril A, Marcus R, Gonter NJ, Maz M, Crowson CS, Dasgupta B.
    J Rheumatol; 2012 Apr; 39(4):795-803. PubMed ID: 22422492
    [Abstract] [Full Text] [Related]

  • 5. EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT).
    Leeb BF, Bird HA, Nesher G, Andel I, Hueber W, Logar D, Montecucco CM, Rovensky J, Sautner J, Sonnenblick M.
    Ann Rheum Dis; 2003 Dec; 62(12):1189-94. PubMed ID: 14644857
    [Abstract] [Full Text] [Related]

  • 6. The polymyalgia rheumatica activity score in daily use: proposal for a definition of remission.
    Leeb BF, Rintelen B, Sautner J, Fassl C, Bird HA.
    Arthritis Rheum; 2007 Jun 15; 57(5):810-5. PubMed ID: 17530664
    [Abstract] [Full Text] [Related]

  • 7. A disease activity score for polymyalgia rheumatica.
    Leeb BF, Bird HA.
    Ann Rheum Dis; 2004 Oct 15; 63(10):1279-83. PubMed ID: 15361387
    [Abstract] [Full Text] [Related]

  • 8. A study of the health assessment questionnaire to evaluate functional status in polymyalgia rheumatica.
    Kalke S, Mukerjee D, Dasgupta B.
    Rheumatology (Oxford); 2000 Aug 15; 39(8):883-5. PubMed ID: 10952744
    [Abstract] [Full Text] [Related]

  • 9. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
    Salvarani C, Macchioni P, Boiardi L, Rossi F, Casadei Maldini M, Mancini R, Beltrandi E, Spacca C, Lodi L, Portioli I.
    J Rheumatol; 1992 Jul 15; 19(7):1100-6. PubMed ID: 1512765
    [Abstract] [Full Text] [Related]

  • 10. Contribution of the polymyalgia rheumatica activity score to glucocorticoid dosage adjustment in everyday practice.
    Cleuziou C, Binard A, De Bandt M, Berthelot JM, Saraux A.
    J Rheumatol; 2012 Feb 15; 39(2):310-3. PubMed ID: 22174199
    [Abstract] [Full Text] [Related]

  • 11. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
    Martinez-Taboada VM, Blanco R, Fito C, Pacheco MJ, Delgado-Rodriguez M, Rodriguez-Valverde V.
    Semin Arthritis Rheum; 2001 Feb 15; 30(4):257-71. PubMed ID: 11182026
    [Abstract] [Full Text] [Related]

  • 12. Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.
    van der Geest KS, Abdulahad WH, Rutgers A, Horst G, Bijzet J, Arends S, Roffel MP, Boots AM, Brouwer E.
    Rheumatology (Oxford); 2015 Aug 15; 54(8):1397-402. PubMed ID: 25724206
    [Abstract] [Full Text] [Related]

  • 13. Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study.
    Salvarani C, Cantini F, Niccoli L, Macchioni P, Consonni D, Bajocchi G, Vinceti M, Catanoso MG, Pulsatelli L, Meliconi R, Boiardi L.
    Arthritis Rheum; 2005 Feb 15; 53(1):33-8. PubMed ID: 15696567
    [Abstract] [Full Text] [Related]

  • 14. Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis.
    Proven A, Gabriel SE, O'Fallon WM, Hunder GG.
    J Rheumatol; 1999 Jun 15; 26(6):1333-7. PubMed ID: 10381052
    [Abstract] [Full Text] [Related]

  • 15. Value of (18)F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment.
    Palard-Novello X, Querellou S, Gouillou M, Saraux A, Marhadour T, Garrigues F, Abgral R, Salaün PY, Devauchelle-Pensec V.
    Eur J Nucl Med Mol Imaging; 2016 Apr 15; 43(4):773-9. PubMed ID: 26753600
    [Abstract] [Full Text] [Related]

  • 16. Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6.
    Cutolo M, Straub RH, Foppiani L, Prete C, Pulsatelli L, Sulli A, Boiardi L, Macchioni P, Giusti M, Pizzorni C, Seriolo B, Salvarani C.
    J Rheumatol; 2002 Apr 15; 29(4):748-56. PubMed ID: 11950017
    [Abstract] [Full Text] [Related]

  • 17. Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica.
    Hutchings A, Hollywood J, Lamping DL, Pease CT, Chakravarty K, Silverman B, Choy EH, Scott DG, Hazleman BL, Bourke B, Gendi N, Dasgupta B.
    Arthritis Rheum; 2007 Jun 15; 57(5):803-9. PubMed ID: 17530680
    [Abstract] [Full Text] [Related]

  • 18. Performance of the polymyalgia rheumatica activity score for diagnosing disease flares.
    Binard A, de Bandt M, Berthelot JM, Saraux A, Inflammatory Joint Disease Working Group of the French Society for Rheumatology.
    Arthritis Rheum; 2008 Feb 15; 59(2):263-9. PubMed ID: 18240260
    [Abstract] [Full Text] [Related]

  • 19. Imbalance between endothelial injury and repair in patients with polymyalgia rheumatica: improvement with corticosteroid treatment.
    Pirro M, Bocci EB, Di Filippo F, Schillaci G, Mannarino MR, Bagaglia F, Gerli R, Mannarino E.
    J Intern Med; 2012 Aug 15; 272(2):177-84. PubMed ID: 22211720
    [Abstract] [Full Text] [Related]

  • 20. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.
    Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H, van der Tempel H, van der Linden S.
    J Rheumatol; 1999 Apr 15; 26(4):980-4. PubMed ID: 10229432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.